Milestone Scientific Corp (MLSS) - Multiplikator forward rega marang pendapatan
Milestone Scientific (MLSS) is battling clinic conservatism and the dominance of budget syringes. The forward price-to-sales ratio helps assess the asset's price volatility, where 2.70 represents the current metric level. Business resilience relies on recurring sales of disposable tips, while growth potential is driven by EU expansion and the implementation of Wand/STA systems in dentistry.
Milestone Scientific Corporation - rincian analitis lan metrik utama (MLSS)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Milestone Scientific|MLSS - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Milestone Scientific|MLSS - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Milestone Scientific Corporation|MLSS - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Milestone Scientific|Rasio cepet milestonescientific.com
- data bathi bisnis lan rasio investasi:
MLSS - Asil keuangan resik|Bathi sing dikarepake Milestone Scientific|MLSS - Rasio rega marang bathi|Pangali Forward P/E Milestone Scientific Corp|MLSS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Milestone Scientific Corporation|MLSS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Milestone Scientific|MLSS - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan milestonescientific.com|MLSS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Milestone Scientific
- data dodolan lan asil:
Analisis umum perusahaan:MLSS (Milestone Scientific Inc.)
The forward P/S ratio assesses the market value of a business relative to expected revenue, allowing for a determination of the premium paid for sales growth potential. By analyzing the forward P/S of Milestone Scientific (MLSS), an investor can diagnose the adequacy of the asset's price, taking into account the risks associated with outsourcing serial production and the critical dependence on the quality of third-party contract vendors.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan STAAR Surgical Co|NAGE (ChromaDex Corporation) - Multiplikator Forward P/S|zimvie.com (ZIMV) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|Rasio rega marang prakiraan pendapatan CERS (Cerus Corp.)|Multiplikator Forward P/S TKNO (Alpha Teknova Inc)|Monogram Orthopedics Inc. (MGRM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|STSS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake InfuSystem Holdings INFU|UTMD (Utah Medical Products, Inc.) - Multiplikator forward rega marang pendapatan|KRMD: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Nyxoah, S.A.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Microbot Medical, Inc MBOT|Rasio rega marang prakiraan pendapatan Pro-Dex, Inc. (PDEX)|zentek.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S ELUT (Elutia)|NEXGEL Inc. (NXGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|RVP: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan HBIO (harvardbioscience.com)|Femasys Inc. (FEMY) - Rasio rega marang prakiraan pendapatan|MHUA - Rasio kapitalisasi marang dodolan sing dikarepake|POAI (Predictive Oncology Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Callan JMB Corp (CJMB)|Multiplikator Forward P/S ATRI|Rasio kapitalisasi marang dodolan sing dikarepake NeuroMetrix Corporation
